Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2021

01-02-2021 | Allergic Rhinitis | Research Article

Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study

Authors: Hélio Guedes, Manuel Morgado, Márcio Rodrigues, Agostinho Cruz, Cecília Fonseca, Elísio Costa, André R. T. S. Araujo

Published in: International Journal of Clinical Pharmacy | Issue 1/2021

Login to get access

Abstract

Background Allergic rhinitis represents a public health problem that is significantly prevalent in the global population and has been associated with asthma, a strong desire to sleep and a low quality of life. Objective This study aims to evaluate the prevalence, symptoms, control strategies and treatment, as well as the control of this condition and its impact on the quality of life of customers of community pharmacies with allergic rhinitis. Setting A questionnaire survey was carried out in nine community pharmacies in the city of Guarda, Portugal. Method In this cross-sectional study, data was collected by an interview between May 2014 and December 2014. The control of the illness and the impact of allergic rhinitis on the quality of life were assessed through a CARAT10 test and a WHOQOL-BREF instrument, respectively. Main outcome measure The impact of allergic rhinitis on the patient’s quality of life. Results The estimated prevalence of allergic rhinitis was between 10.8% and 15.4%, from which 63 and 42 individuals were medically and symptomatically diagnosed, respectively, from a study population of 804 respondents. The majority of participants (57.1%) suffered from the symptoms more than twice a year. The symptoms, such as difficulty in falling asleep, repeated and continuous sneezing and bilateral nasal obstruction, were severe. There were patients with uncontrolled allergic rhinitis symptoms after the CARAT10 test, even when the individual’s perception of the quality of life was good according to the WHOQOL-BREF score, with gender differences in the psychological domain. It should also be emphasized that there was a significant association between higher education levels with better control of the illness/quality of life. Additionally, most participants used pharmacological treatment (not alternative therapies) and the adoption of self-management measures to relieve their symptoms. Conclusions The findings of this study showed that the estimated prevalence of allergic rhinitis seems to be apparently lower in Guarda than that found in the general Portuguese population. From the data, some patients showed uncontrolled allergic rhinitis symptoms, strengthening the importance of the role of intervention by a health professional.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morais-Almeida M, Loureiro C, Todo-Bom A, Nunes C, Pereira C, Delgado L, et al. Avaliação da prevalência e caracterização da rinite em utentes dos cuidados de saúde primários de Portugal Continental-Estudo ARPA. Rev Port Imunoalergologia. 2005;13:69–80. Morais-Almeida M, Loureiro C, Todo-Bom A, Nunes C, Pereira C, Delgado L, et al. Avaliação da prevalência e caracterização da rinite em utentes dos cuidados de saúde primários de Portugal Continental-Estudo ARPA. Rev Port Imunoalergologia. 2005;13:69–80.
2.
go back to reference Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758–64.CrossRef Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758–64.CrossRef
4.
go back to reference Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11:1646–62.CrossRef Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11:1646–62.CrossRef
6.
go back to reference Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65:1042–8.CrossRef Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65:1042–8.CrossRef
9.
go back to reference Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171–6.CrossRef Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171–6.CrossRef
10.
go back to reference Canavarro MC, Vaz Serra A, Pereira M, Simões MR, Quartilho MJ, Rijo D, et al. WHOQOL disponível para Portugal: desenvolvimento dos instrumentos de avaliação da qualidade de vida da Organização Mundial de Saúde (WHOQOL-100 e WHOQOL-BREF). In: Canavarro MC, Vaz Serra A, editors. Qualidade de vida e saúde: Uma abordagem na perspectiva da Organização Mundial de Saúde Lisboa: Fundação Calouste Gulbenkian; 2010. pp. 171–190. Canavarro MC, Vaz Serra A, Pereira M, Simões MR, Quartilho MJ, Rijo D, et al. WHOQOL disponível para Portugal: desenvolvimento dos instrumentos de avaliação da qualidade de vida da Organização Mundial de Saúde (WHOQOL-100 e WHOQOL-BREF). In: Canavarro MC, Vaz Serra A, editors. Qualidade de vida e saúde: Uma abordagem na perspectiva da Organização Mundial de Saúde Lisboa: Fundação Calouste Gulbenkian; 2010. pp. 171–190.
11.
go back to reference Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis. 2012;6:25–39.CrossRef Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis. 2012;6:25–39.CrossRef
12.
go back to reference Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol. 2002;88:2–7.CrossRef Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol. 2002;88:2–7.CrossRef
13.
go back to reference Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6:11–23.CrossRef Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6:11–23.CrossRef
14.
go back to reference O’Connor J, Seeto C, Saini B, Bosnic-Anticevich S, Krass I, Armour C, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns. 2008;70:111–7.CrossRef O’Connor J, Seeto C, Saini B, Bosnic-Anticevich S, Krass I, Armour C, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns. 2008;70:111–7.CrossRef
15.
go back to reference May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39:2410–9.CrossRef May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39:2410–9.CrossRef
18.
go back to reference Lourenco O, Calado S, Sa-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Pharm. 2014;20:513–22.CrossRef Lourenco O, Calado S, Sa-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Pharm. 2014;20:513–22.CrossRef
19.
go back to reference Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.CrossRef Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.CrossRef
20.
go back to reference Thompson A, Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation. Ann Allergy Asthma Immunol. 2013;111:446–51.CrossRef Thompson A, Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation. Ann Allergy Asthma Immunol. 2013;111:446–51.CrossRef
22.
go back to reference Smith L, Nguyen T, Seeto C, Saini B, Brown L. The role of non-clinicians in a goal setting model for the management of allergic rhinitis in community pharmacy settings. Patient Educ Couns. 2011;85:e26–32.CrossRef Smith L, Nguyen T, Seeto C, Saini B, Brown L. The role of non-clinicians in a goal setting model for the management of allergic rhinitis in community pharmacy settings. Patient Educ Couns. 2011;85:e26–32.CrossRef
23.
go back to reference Wang Y, Chen H, Zhu R, Liu G, Huang N, Li W, et al. Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study. Allergy. 2016;71:1612–9.CrossRef Wang Y, Chen H, Zhu R, Liu G, Huang N, Li W, et al. Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study. Allergy. 2016;71:1612–9.CrossRef
24.
go back to reference Wang Y, Zhu R, Liu G, Li W, Chen H, Daures JP, et al. Prevalence of uncontrolled allergic rhinitis in Wuhan, China: a prospective cohort study. Am J Rhinol Allergy. 2014;28:397–403.CrossRef Wang Y, Zhu R, Liu G, Li W, Chen H, Daures JP, et al. Prevalence of uncontrolled allergic rhinitis in Wuhan, China: a prospective cohort study. Am J Rhinol Allergy. 2014;28:397–403.CrossRef
25.
go back to reference Bosnic-Anticevich S, Costa E, Menditto E, Lourenco O, Novellino E, Bialek S, et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”. Allergy. 2019;74:1219–36.PubMed Bosnic-Anticevich S, Costa E, Menditto E, Lourenco O, Novellino E, Bialek S, et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”. Allergy. 2019;74:1219–36.PubMed
26.
go back to reference Bousquet J, Bedbrook A, Czarlewski W, Onorato GL, Arnavielhe S, Laune D, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16.CrossRef Bousquet J, Bedbrook A, Czarlewski W, Onorato GL, Arnavielhe S, Laune D, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16.CrossRef
27.
go back to reference Castillo Vizuete JA, Sastre J, Del Cuvillo BA, Picado C, Martinez Moragon E, Ignacio Garcia JM, et al. Asthma, rhinitis, and nasal polyp multimorbidities. Arch Bronconeumol. 2019;55:146–55.CrossRef Castillo Vizuete JA, Sastre J, Del Cuvillo BA, Picado C, Martinez Moragon E, Ignacio Garcia JM, et al. Asthma, rhinitis, and nasal polyp multimorbidities. Arch Bronconeumol. 2019;55:146–55.CrossRef
28.
go back to reference Kalpaklioǧlu AF, Baççioǧlu A. Evaluation of quality of life: impact of allergic rhinitis on asthma. J Investig Allergol Clin Immunol. 2008;18:168–73.PubMed Kalpaklioǧlu AF, Baççioǧlu A. Evaluation of quality of life: impact of allergic rhinitis on asthma. J Investig Allergol Clin Immunol. 2008;18:168–73.PubMed
29.
go back to reference Maspero J, Lee BW, Katelaris CH, Potter PC, Cingi C, Lopatin A, et al. Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States. Clin Exp Allergy. 2012;42:1684–96.CrossRef Maspero J, Lee BW, Katelaris CH, Potter PC, Cingi C, Lopatin A, et al. Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States. Clin Exp Allergy. 2012;42:1684–96.CrossRef
Metadata
Title
Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study
Authors
Hélio Guedes
Manuel Morgado
Márcio Rodrigues
Agostinho Cruz
Cecília Fonseca
Elísio Costa
André R. T. S. Araujo
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01115-z

Other articles of this Issue 1/2021

International Journal of Clinical Pharmacy 1/2021 Go to the issue

ACKNOWLEDGEMENT

Thank You Reviewers